• Home Healthcare Market Comprehensive Analysis And Industry Outlook To 2027 | Abbott, McKesson Corporation, F. Hoffmann-La Roche Ltd, OMRON Corporation, Medtronic

  The "Global Home Healthcare Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a focused global... Tuesday December 24, 2019 | Empowered News

• Home Healthcare Market Comprehensive Analysis And Industry Outlook To 2027 | Abbott, McKesson Corporation, F. Hoffmann-La Roche Ltd, OMRON Corporation, Medtronic

  The "Global Home Healthcare Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a focused global... Tuesday December 24, 2019 | Empowered News

• Elanco Sells Victoria, PEI, Canada R&D Facility To The Center For Aquaculture Technologies Canada (CATC)

  GREENFIELD, Ind.--(BUSINESS WIRE)--Dec 24, 2019-- Elanco Animal Health Incorporated (NYSE: ELAN) has signed an agreement to sell its... Tuesday December 24, 2019 | West Plains Daily Quill

• Global Dermatology Steroids Market Anticipated To Worth A Value Of USD 1.8 Billion By 2027|Pfizer, GlaxoSmithKline Plc., LEO Pharma

  The global Dermatology Steroids Market is segmented into by Formulations into Cream, Gels, Lotions, Solutions, Tapes, and others; By... Tuesday December 24, 2019 | Fox 21 Delmarva

• Global Dermatology Steroids Market Anticipated To Worth A Value Of USD 1.8 Billion By 2027|Pfizer, GlaxoSmithKline Plc., LEO Pharma

  The global Dermatology Steroids Market is segmented into by Formulations into Cream, Gels, Lotions, Solutions, Tapes, and others; By... Tuesday December 24, 2019 | WBOC Tv 16

• Elanco Sells Victoria, PEI, Canada R&D Facility To The Center For Aquaculture Technologies Canada (CATC) | Spoke

  Elanco Sells Victoria, PEI, Canada R&D Facility to The Center for Aquaculture Technologies Canada (CATC) Elanco Sells Victoria, PEI, Canada... Tuesday December 24, 2019 | Spoke

• Global Specialty Generics Market Analysis 2019-2025 : Teva Pharmaceuticals USA, Inc., Mylan N.V., Sandoz International GmbH, Akorn

  Report Specialty Generics covers all aspects of the "Specialty Generics Market". It provides basic market terminology and advanced... Tuesday December 24, 2019 | Globalmarketnews24

• We Have Increased Awareness On Cancer – Dr. Mugisha

  Kampala, Uganda | THE INDEPENDENT | The number of women who report to the Uganda Cancer Institute (UCI) with advanced cervical cancer has... Tuesday December 24, 2019 | The Independent

• Novartis And Amgen Submit Industry Datasets To ASH RC Data Hub

  Dec 05, 2019 (MarketLine via COMTEX News Network) -- Novartis and Amgen have submitted datasets to the ASH Research Collaborative (ASH RC)... Tuesday December 24, 2019 | IDC Chase

• FDA Approves New Treatment For Adults With Migraine

  The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or... Tuesday December 24, 2019 | Rlsmedia

• Could The Way You Make Your Coffee Impact Your Health?

  According to a new study published in the Journal of Internal Medicine, drinking filtered coffee may prevent type 2 diabetes. Tuesday December 24, 2019 | Bicycling

• Wellness Tourism Market 2019 Key Players Analysis By: Accor, Allergan, Canyon Ranch, Carlson Rezidor, Four Seasons, Fitpacking, Galderma, Hilton, Hyatt, IHG, Ipsen, KPJ Healthcare

  “Wellness Tourism” Market research report highlights the major details and provides in-depth analysis of the market along with the future... Tuesday December 24, 2019 | Montana Ledger

• Federal Circuit Affirms Safe Harbor Ruling And $70 Million Award In Amgen Inc. V. Hospira, Inc.

  On December 16, 2019, the Court of Appeals for the Federal Circuit issued an opinion that fully upheld the District of Delaware’s denial of... Tuesday December 24, 2019 | JD Supra

• Migraine Treatment, Ubrelvy, Receives FDA Approval

  The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or... Tuesday December 24, 2019 | Outbreak News Today

• Migraine Treatment, Ubrelvy, Receives FDA Approval

  The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or... Tuesday December 24, 2019 | Outbreak News Today

• China To Lower Import Tariffs On Over 850 Products By Jan. 1

  China will lower tariffs on more than 850 products starting next year as Beijing looks to promote high-quality development of trade, the... Tuesday December 24, 2019 | 1stnews

• China To Lower Import Tariffs On Over 850 Products By Jan. 1

  China will lower tariffs on more than 850 products starting next year as Beijing looks to promote high-quality development of trade, the... Tuesday December 24, 2019 | 1stnews

• Taking Certain Vitamins During Breast Cancer Chemo Tied To Recurrence, Death

  Patients with breast cancer who use supplements during chemotherapy may be at an increased risk of recurrence and death, a new study... Monday December 23, 2019 | XYZ News - Nigeria

• Tariffs Revised On Some Products

  CHINA will adjust import tariffs for a range of products starting January 1, 2020 to promote high-quality development of trade, the Customs... Monday December 23, 2019 | Shanghai Daily

• Tariffs Revised On Some Products

  CHINA will adjust import tariffs for a range of products starting January 1, 2020 to promote high-quality development of trade, the Customs... Monday December 23, 2019 | Shanghai Daily

• القهوة المفلترة “تخفي” فائدة صحية قيّمة لا تقدمها المغلية

  أظهرت دراسة تتبعت مئات المشاركين لمدة 7 سنوات، أن شرب القهوة المصفاة (أو المفلترة) قد يقلل من خطر الإصابة بداء السكري النوع 2. وشملت... Monday December 23, 2019 | Al-Sharq Times - الشرق تايمز

• القهوة المفلترة “تخفي” فائدة صحية قيّمة لا تقدمها المغلية

  أظهرت دراسة تتبعت مئات المشاركين لمدة 7 سنوات، أن شرب القهوة المصفاة (أو المفلترة) قد يقلل من خطر الإصابة بداء السكري النوع 2. وشملت... Monday December 23, 2019 | Al-Sharq Times - الشرق تايمز

• CHINA TO LOWER IMPORT TARIFFS FOR SOME PRODUCTS

  CHINA will adjust import tariffs for a range of products starting Jan. 1 to promote high-quality development of trade, the Customs Tariff... Monday December 23, 2019 | Shenzhen Daily

• Analysis On The World’s $140+ Billion Pain Management Drugs Market, 2019-2024 – Featuring Novartis, Eli Lilly, Amgen, GSK, AbbVie, And More – ResearchAndMarkets.com

  DUBLIN --(BUSINESS WIRE) The "Pain Management Drugs Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's... Monday December 23, 2019 | WRCB-TV 3

• Analysis On The World’s $140+ Billion Pain Management Drugs Market, 2019-2024 – Featuring Novartis, Eli Lilly, Amgen, GSK, AbbVie, And More – ResearchAndMarkets.com

  DUBLIN --(BUSINESS WIRE) The "Pain Management Drugs Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's... Monday December 23, 2019 | WRCB-TV 3

• FDA Approves New Treatment For Adults With Migraine

  For Immediate Release: December 23, 2019 The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute... Monday December 23, 2019 | EIN Presswire

• FDA Approves New Treatment For Adults With Migraine

  For Immediate Release: December 23, 2019 The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute... Monday December 23, 2019 | EIN Presswire

• Allergan’s Migraine Treatment Approved By FDA

  The Food and Drug Administration said it has approved Ubrelvy, Allergan PLC's (AGN) migraine tablets. Allergan USA Inc., an Allergan... Monday December 23, 2019 | InvestorsHub

• Analysis On The World’s $140+ Billion Pain Management Drugs Market, 2019-2024 – Featuring Novartis, Eli Lilly, Amgen, GSK, AbbVie, And More – ResearchAndMarkets.com | Spoke

  Analysis on the World's $140+ Billion Pain Management Drugs Market, 2019-2024 - Featuring Novartis, Eli Lilly, Amgen, GSK, AbbVie, and More... Monday December 23, 2019 | Spoke

• Allergan (AGN) Granted FDA Approval For UBRELVY (ubrogepant)

  Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for... Monday December 23, 2019 | StreetInsider.com

• Breast Implant Lymphoma Risk From Allergan Biocell Known By Manufacturer Since 2011: Lawsuit

  A group of women have anonymously filed a class action lawsuit against Allergan over its recalled Biocell breast implants and tissue... Monday December 23, 2019 | AboutLawsuits

• Allergan : Migraine Treatment Approved By FDA

  By Dave Sebastian The Food and Drug Administration said it has approved Ubrelvy, Allergan PLC's (AGN) migraine tablets. Allergan USA... Monday December 23, 2019 | Market Screener

• Analysis On The World’s $140+ Billion Pain Management Drugs Market, 2019-2024 – Featuring Novartis, Eli Lilly, Amgen, GSK, AbbVie, And More – ResearchAndMarkets.com

  The "Pain Management Drugs Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering. The pain... Monday December 23, 2019 | Crain BusinessInsurance - FinancialContent

• Analysis On The World’s $140+ Billion Pain Management Drugs Market, 2019-2024 – Featuring Novartis, Eli Lilly, Amgen, GSK, AbbVie, And More – ResearchAndMarkets.com

  The "Pain Management Drugs Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering. The pain... Monday December 23, 2019 | Crain BusinessInsurance - FinancialContent

• Why Is The Telemedicine Not Used More Often?

  With the rapid development of computing technology, the medical field has also changed drastically with the increase of convenience,... Monday December 23, 2019 | South Africa Today

• Why Is The Telemedicine Not Used More Often?

  With the rapid development of computing technology, the medical field has also changed drastically with the increase of convenience,... Monday December 23, 2019 | South Africa Today

• Allergan (AGN) Receives FDA Approval For New Treatment For Adults With Migraine

  The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or... Monday December 23, 2019 | StreetInsider.com

• Allergan (AGN) Receives FDA Approval For New Treatment For Adults With Migraine

  The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or... Monday December 23, 2019 | StreetInsider.com

• Medical Device Failures Brought To Light Now Bolster Lawsuits And Research

  A vast cache of records that were released this summer are taking on a life of their own. Monday December 23, 2019 | Press-Enterprise

• Medical Device Failures Brought To Light Now Bolster Lawsuits And Research

  A vast cache of records that were released this summer are taking on a life of their own. Monday December 23, 2019 | Press-Enterprise